Literature DB >> 19276075

The second transmembrane domain of the human type 1 angiotensin II receptor participates in the formation of the ligand binding pocket and undergoes integral pivoting movement during the process of receptor activation.

Ivana Domazet1, Brian J Holleran, Stéphane S Martin, Pierre Lavigne, Richard Leduc, Emanuel Escher, Gaétan Guillemette.   

Abstract

The octapeptide hormone angiotensin II (AngII) exerts a wide variety of cardiovascular effects through the activation of the angiotensin II type-1 (AT(1)) receptor, which belongs to the G protein-coupled receptor superfamily. Like other G protein-coupled receptors, the AT(1) receptor possesses seven transmembrane domains that provide structural support for the formation of the ligand-binding pocket. In order to identify those residues in the second transmembrane domain (TMD2) that contribute to the formation of the binding pocket of the AT(1) receptor, we used the substituted cysteine accessibility method. All of the residues within the Leu-70 to Trp-94 region were mutated one at a time to a cysteine, and, after expression in COS-7 cells, the mutant receptors were treated with the sulfhydryl-specific alkylating agent methanethiosulfonate-ethylammonium (MTSEA). MTSEA reacts selectively with water-accessible, free sulfhydryl groups of endogenous or introduced point mutation cysteines. If a cysteine is found in the binding pocket, the covalent modification will affect the binding kinetics of the ligand. MTSEA substantially decreased the binding affinity of D74C-AT(1), L81C-AT(1), A85C-AT(1), T88C-AT(1), and A89C-AT(1) mutant receptors, which suggests that these residues orient themselves within the water-accessible binding pocket of the AT(1) receptor. Interestingly, this pattern of acquired MTSEA sensitivity was altered for TMD2 reporter cysteines engineered in a constitutively active N111G-AT(1) receptor background. Indeed, mutant D74C-N111G-AT(1) became insensitive to MTSEA, whereas mutant L81C-N111G-AT(1) lost some sensitivity and mutant V86C-N111G-AT(1) became sensitive to MTSEA. Our results suggest that constitutive activation of the AT(1) receptor causes TMD2 to pivot, bringing the top of TMD2 closer to the binding pocket and pushing the bottom of TMD2 away from the binding pocket.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276075      PMCID: PMC2673261          DOI: 10.1074/jbc.M808113200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: contributions of the second membrane-spanning segment.

Authors:  J A Javitch; J A Ballesteros; J Chen; V Chiappa; M M Simpson
Journal:  Biochemistry       Date:  1999-06-22       Impact factor: 3.162

Review 2.  A review of mutagenesis studies of angiotensin II type 1 receptor, the three-dimensional receptor model in search of the agonist and antagonist binding site and the hypothesis of a receptor activation mechanism.

Authors:  Y Inoue; N Nakamura; T Inagami
Journal:  J Hypertens       Date:  1997-07       Impact factor: 4.844

Review 3.  G protein-coupled receptors. II. Mechanism of agonist activation.

Authors:  U Gether; B K Kobilka
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

4.  Role of N-glycosylation in the expression and functional properties of human AT1 receptor.

Authors:  P M Lanctôt; P C Leclerc; E Escher; R Leduc; G Guillemette
Journal:  Biochemistry       Date:  1999-07-06       Impact factor: 3.162

5.  A computer modeling postulated mechanism for angiotensin II receptor activation.

Authors:  M P Joseph; B Maigret; J C Bonnafous; J Marie; H A Scheraga
Journal:  J Protein Chem       Date:  1995-07

6.  Determination of peptide contact points in the human angiotensin II type I receptor (AT1) with photosensitive analogs of angiotensin II.

Authors:  S A Laporte; A A Boucard; G Servant; G Guillemette; R Leduc; E Escher
Journal:  Mol Endocrinol       Date:  1999-04

7.  The conformational change responsible for AT1 receptor activation is dependent upon two juxtaposed asparagine residues on transmembrane helices III and VII.

Authors:  A J Balmforth; A J Lee; P Warburton; D Donnelly; S G Ball
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

8.  Conformational changes in rhodopsin. Movement of helix f detected by site-specific chemical labeling and fluorescence spectroscopy.

Authors:  T D Dunham; D L Farrens
Journal:  J Biol Chem       Date:  1999-01-15       Impact factor: 5.157

9.  Mechanism of constitutive activation of the AT1 receptor: influence of the size of the agonist switch binding residue Asn(111).

Authors:  Y H Feng; S Miura; A Husain; S S Karnik
Journal:  Biochemistry       Date:  1998-11-10       Impact factor: 3.162

10.  A cysteine residue in the third membrane-spanning segment of the human D2 dopamine receptor is exposed in the binding-site crevice.

Authors:  J A Javitch; X Li; J Kaback; A Karlin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

View more
  8 in total

1.  Ligand-mimicking receptor variant discloses binding and activation mode of prolactin-releasing peptide.

Authors:  Daniel Rathmann; Diana Lindner; Stephanie H DeLuca; Kristian W Kaufmann; Jens Meiler; Annette G Beck-Sickinger
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

Review 2.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

3.  Critical hydrogen bond formation for activation of the angiotensin II type 1 receptor.

Authors:  Jérôme Cabana; Brian Holleran; Marie-Ève Beaulieu; Richard Leduc; Emanuel Escher; Gaétan Guillemette; Pierre Lavigne
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

4.  The fifth transmembrane domain of angiotensin II Type 1 receptor participates in the formation of the ligand-binding pocket and undergoes a counterclockwise rotation upon receptor activation.

Authors:  Ivana Domazet; Stéphane S Martin; Brian J Holleran; Marie-Eve Morin; Patrick Lacasse; Pierre Lavigne; Emanuel Escher; Richard Leduc; Gaétan Guillemette
Journal:  J Biol Chem       Date:  2009-09-22       Impact factor: 5.157

5.  Analysis of transmembrane domains 1 and 4 of the human angiotensin II AT1 receptor by cysteine-scanning mutagenesis.

Authors:  Liping Yan; Brian J Holleran; Pierre Lavigne; Emanuel Escher; Gaétan Guillemette; Richard Leduc
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

6.  Activation induces structural changes in the liganded angiotensin II type 1 receptor.

Authors:  Martin Clément; Jérôme Cabana; Brian J Holleran; Richard Leduc; Gaétan Guillemette; Pierre Lavigne; Emanuel Escher
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

7.  Multidimensional scaling reveals the main evolutionary pathways of class A G-protein-coupled receptors.

Authors:  Julien Pelé; Hervé Abdi; Matthieu Moreau; David Thybert; Marie Chabbert
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

8.  Identification of a New Cholesterol-Binding Site within the IFN-γ Receptor that is Required for Signal Transduction.

Authors:  Ornella Morana; Jon Ander Nieto-Garai; Patrik Björkholm; Jorge Bernardino de la Serna; Oihana Terrones; Aroa Arboleya; Dalila Ciceri; Iratxe Rojo-Bartolomé; Cédric M Blouin; Christophe Lamaze; Maier Lorizate; Francesc-Xabier Contreras
Journal:  Adv Sci (Weinh)       Date:  2022-02-15       Impact factor: 16.806

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.